A continuous peptide epitope reacting with pandemic influenza AH1N1 predicted by bioinformatic approaches

Journal of Molecular Recognition : JMR
Jonathan P Carrillo-VazquezAbsalom Zamorano-Carrillo

Abstract

Computational identification of potential epitopes with an immunogenic capacity challenges immunological research. Several methods show considerable success, and together with experimental studies, the efficiency of the algorithms to identify potential peptides with biological activity has improved. Herein, an epitope was designed by combining bioinformatics, docking, and molecular dynamics simulations. The hemagglutinin protein of the H1N1 influenza pandemic strain served as a template, owing to the interest of obtaining a scheme of immunization. Afterward, we performed enzyme-linked immunosorbent assay (ELISA) using the epitope to analyze if any antibodies in human sera before and after the influenza outbreak in 2009 recognize this peptide. Also, a plaque reduction neutralization test induced by virus-neutralizing antibodies and the IgG determination showed the biological activity of this computationally designed peptide. The results of the ELISAs demonstrated that the serum of both prepandemic and pandemic recognized the epitope. Moreover, the plaque reduction neutralization test evidenced the capacity of the designed peptide to neutralize influenza virus in Madin-Darby canine cells.

References

Jun 1, 1992·The Journal of Experimental Medicine·H KropshoferH Kalbacher
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J NovotnýG D Rose
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·H M GeysenR H Meloen
Jan 1, 1987·Annual Review of Biochemistry·D C Wiley, J J Skehel
Jan 1, 1984·Annual Review of Immunology·D C BenjaminE M Prager
Apr 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·F Sinigaglia, J Hammer
Jul 4, 1998·The Journal of Infectious Diseases·L SimonsenK Fukuda
Oct 8, 1999·Emerging Infectious Diseases·M I MeltzerK Fukuda
Mar 29, 2000·Biochemical and Biophysical Research Communications·P GogolákG K Tóth
Dec 26, 2001·Bioinformatics·H Singh, G P Raghava
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J M Wood
Apr 30, 2002·International Archives of Allergy and Immunology·Yun LuYing-Hua Chen
Jul 12, 2002·Proteins·Lorna J SmithWilfred F van Gunsteren
Aug 21, 2002·The Journal of Experimental Medicine·Ana-Maria Lennon-DuménilCécile Lagaudrière-Gesbert
Nov 14, 2002·Annual Review of Genetics·David A Steinhauer, John J Skehel
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Renée MénezEnrico A Stura
May 16, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joshua B Plotkin, Jonathan Dushoff
Dec 3, 2003·Trends in Immunology·Darren R Flower
Mar 10, 2005·Vaccine·Akira YanoTosiki Nisizawa
Mar 12, 2005·PLoS Biology·Bjoern PetersAlessandro Sette
Mar 18, 2005·Annual Review of Immunology·E Sergio Trombetta, Ira Mellman
Apr 13, 2005·Biochemical and Biophysical Research Communications·Constanza CárdenasManuel E Patarroyo
Oct 29, 2005·The Lancet Infectious Diseases·Ron Eccles
Jan 26, 2006·Bioinformatics·Violaine MoreauFranck Molina
Mar 23, 2006·Annual Review of Immunology·Markus G RudolphIan A Wilson
Apr 22, 2006·Science·Jocelyn Kaiser
Sep 27, 2006·Protein Science : a Publication of the Protein Society·Pernille Haste AndersenOle Lund
Jan 24, 2007·Proteins·Alan GrossfieldMichael C Pitman
Mar 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Arthur Chun-Chieh ShihWen-Hsiung Li
Oct 4, 2007·BMC Structural Biology·Julia V Ponomarenko, Philip E Bourne
Nov 2, 2007·BMC Bioinformatics·Mette V LarsenMorten Nielsen

❮ Previous
Next ❯

Citations

Feb 16, 2020·Archives of Virology·G Lizbeth Ramírez-SalinasJosé Correa-Basurto
Jan 1, 2020·BMC Bioinformatics·Vincent DemolombeViolaine Moreau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.